Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Replacing decommissioned renewables will take solar and wind installations to new heights as 2.5 TW of projects reach end of life by the 2040s
-
Gold Mining Entering a Potentially Explosive New Phase as Gold Hovers Above $4,300/oz
-
Cuentas Inc. to Present at the Financial Services Virtual Investor Conference September 24th
-
MindWave Innovations Signs Agreement to Build and Operate AQUAEChain, a Platform for Insured ALCI Credits
-
Cloudastructure Management Discusses Enterprise Growth Strategy at Water Tower Research Insights Conference
-
Nightfood Holdings Inc. (OTCQB: NGTF) Forms Manufacturing Subsidiary to Scale Up Output of Automated Wafer Sorter, AOI Systems
-
Stolt-Nielsen Limited to Host a Video Conference to Present the Results for the Third Quarter and First Nine Months of 2026
-
Polar Power CEO Arthur Sams Converts $614,700 of Debt Into Preferred Equity, Strengthening Balance Sheet
-
Applied Biologics Announces Publication of New XWRAP® Translational Research Demonstrating More Favorable Wound-Healing Biology
-
Form 8.3 - NextEnergy Solar Fund Limited
-
HCW Biologics Announces Pricing of $1.5 Million Private Placement
-
Form 8.3 - Eleco Plc
-
Free Family Fun Night in Cedar Park: Ally Medical ER Ribbon Cutting
-
SeaStar Medical Congratulates H. David Humes, M.D., on Receiving the University of Michigan 2026 Distinguished University Innovator of the Year for Development of the SCD Therapy
-
Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments
-
Order.co Launches Purchasing Copilot, Bringing AI-Powered Procurement Into Workday
-
IMUNON Makes the Frontline Case for Phase 3 IMNN-001 Study: 14.7-Month OS Signal, Historical IL-12 Safety Barriers Overcome, Enrolling Ahead of Plan
-
Founder and CEO of Zomee, Dina Shanowitz, Named Finalist in the 2026 Stevie® Awards for Women in Business
-
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), Lantheus Holdings Inc. (N
-
Optimove Partners with Plaee to Bring Prediction Markets to Its Global Operator Network
-
Claris Bio Establishes Corporate Headquarters in San Francisco
-
Collective Metals Announces Appointment of Curtis Riou to its Board of Directors
-
ABM Wins 2026 Gartner Marketing and Communications Award for Brand and Reputation Excellence
-
Elicio Therapeutics Announces Late-Breaking Phase 2 AMPLIFY-7P Data Selected for Proffered Paper Oral Presentation at ESMO Congress 2026
-
Annexon to Present Patient Baseline Characteristics from Vonaprument Phase 3 ARCHER II Pivotal Trial for Geographic Atrophy at The Retina Society 59th Annual Scientific Meeting
-
Nuvectis Announces NXP200 Granted Breakthrough Therapy Designation in China for BRAF V600-Mutant, Recurrent or Progressive, High-Grade Glioma
-
Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR
-
EBANX advances emerging market infrastructure with Pakistan expansion in motion and native Apple Pay decryption
-
New Generation Consumer Group, Inc. (OTC: NGCG) Signs Letter of Intent for Proposed Strategic Business Combination with Nutrien Mineral Limited
-
La Mancha Investments S. à r. l. to File Early Warning Report
-
Trident Regains Compliance with Nasdaq Minimum Market Value of Listed Securities Requirement
-
Primmune Therapeutics Announces Enrollment Milestone in Phase 2 INFLECTION–003 Study of Polvitolimod HCl in Neoadjuvant Melanoma
-
Precision Neuroscience Closes Oversubscribed $250M Series D Led by Pershing Square Inc., the Ackman Oxman Institute, and a Leading Life Sciences Investment Fund
-
Drug Developers Deploy In Silico Drug Safety Prediction Models From Deep Origin’s ARPA-H-Funded PREDICTS Consortium
-
SkyAI Comments on Annual Meeting Results
-
Boehringer Ingelheim and WHO Foundation launch global collaboration to close the gap in obesity and metabolic health
-
Quantum Biopharma Licensee Unbuzzd Wellness to Advance Clinically Validated Alcohol Metabolism Accelerant After Appointing Zappy as CEO
-
Dillard’s Offers Exclusive Southern Living Christmas Cookbook
-
Getty Realty Corp. to Report Third Quarter 2026 Financial Results
-
IBN Announces Latest Episode of The MiningNewsWire Podcast featuring Dr. Bo Møller Stensgaard, President of Greenland Mines Ltd.
-
Liner Launches Liner Model API to Cut Enterprise LLM Costs by More Than 50%
-
Diginex Consolidates Group-Wide Expertise and Launches Sustainability Science & Intelligence Initiative to Accelerate Product Innovation and Drive Measurable Client Outcomes
-
Biolinq Shine™ Receives FDA 510(k) Clearance for Over-the-Counter Use
-
Synack Expands Access to AI and Human Penetration Testing Across Cloud and Public Sector Marketplaces
-
ZenaTech’s ZenaDrone Advances Defense-Focused Quantum Navigation System for GPS-Denied Operations to Drone Testing Phase
-
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026
-
Flux Launches New AI Capabilities to Take Hardware Designs From PCB to Prototype
-
Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis
-
HTVRONT Makes PRINTING United Expo Debut with Expanded Personalization Portfolio
-
New Preclinical Data Further Support Potential for Tvardi’s STAT3 Inhibitors in Ulcerative Colitis (UC)
